TREA

99007063 - OUTPACE

Follow

Information

  • Trademark
  • 99007063
  • Serial Number
    99007063
  • Filing Date
    January 17, 2025
    10 months ago
  • Transaction Date
    July 17, 2025
    4 months ago
  • Status Date
    July 03, 2025
    4 months ago
  • Location Date
    July 03, 2025
    4 months ago
  • Status Code
    641
  • Current Location
    TMO LAW OFFICE 303
    Employee Name
    THINGVOLD,CALDER J
  • Attorney Docket Number
    T-4830/2 US
    Attorney Name
    Sydney R. Jensen
    Law Office Assigned Location Code
    T40
  • Owners
Information
Mark Drawing Code
4
Mark Identification
OUTPACE
Case File Statements
  • GS0421: Drug discovery and development; product research and development; scientific research and development services; pharmaceutical research and development; development of pharmaceutical preparations and drugs; identification, production and development of therapeutics, cell therapies, bioengineered cells and proteins for the treatment and prevention of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; identification, production and development of cell therapy solutions, namely protein design and custom cell programming; scientific, medical, biotechnology, biomedical, and pharmaceutical research, development, testing and analysis services; protein engineering and design services; cell programming services; research, development, discovery and consulting services in the fields of cell therapy and immuno-oncology; research, development, engineering and testing services in the fields of therapeutics, cell therapies, biologics, medicine, and pharmaceuticals; medical and clinical research and development services; scientific research and development, scientific laboratory services, medical and scientific research, biotechnology research and synthetic biology research, all of the foregoing relating to human beings; development of pharmaceutical preparations and drugs for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; development of pharmaceutical preparations and drugs in the field of gene therapy; medical research laboratory services, namely, tissue material processing and analysis in the field of cell therapy and immuno-oncology; biotechnology laboratory services; scientific and medical laboratory services; genetic engineering services; engineering of biological cells, cellular targets, proteins, and antibodies for others; providing a website featuring information in the scientific, medical, biotechnology, biomedical, and pharmaceutical fields; provision of drug discovery, development and testing information; providing a website featuring information in the field of drug discovery, development and testing; provision of information in the field of prevention and treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; providing a website featuring information in the field of prevention and treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders; provision of information in the field of cell therapy and immuno-oncology; providing a website featuring information in the field of cell therapy and immuno-oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing a website featuring information in the field of pharmaceuticals and clinical trials; provision of scientific, medical, biotechnology, biomedical, and pharmaceutical information; providing information relating to the diagnostic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of human diseases, disorders and conditions;
Case File Event Statements
  • 1/17/2025 - 10 months ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/17/2025 - 10 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/3/2025 - 4 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/3/2025 - 4 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/27/2025 - 4 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/3/2025 - 4 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT